Novel Immune Modulator Promising in Acute Respiratory Distress Syndrome

(MedPage Today) -- PHOENIX -- A novel exosome-based immunomodulatory agent appeared promising in speeding recovery from acute respiratory distress syndrome (ARDS), a phase IIb trial showed. The inhaled therapy substantially increased the proportion...